Literature DB >> 27839523

Impact of sickle cell anaemia on cardiac chamber size in the paediatric population.

Philippe M Adjagba1, Gaston Habib1, Nancy Robitaille2, Yves Pastore2, Marie-Josée Raboisson1, Daniel Curnier3, Nagib Dahdah1.   

Abstract

Purpose Sickle cell disease is known to cause various degrees of vasculopathy, including impact on heart function. The aims of this single-centre, retrospective study were to assess cardiac chamber size and function and the relationship with haematological indices such as haemoglobin, aspartate aminotransferase, reticulocytosis and bilirubin, lactate dehydrogenase in sickle cell disease.
METHODS: Right ventricle and left ventricle diastolic diameters, left ventricle mass estimate, left ventricle shortening fraction, myocardial performance index, and an index of myocardial relaxation (E/E') were calculated and correlated with haematological parameters.
RESULTS: A total of 110 patients (65% haemoglobin SS, 29% haemoglobin SC) were studied at a mean age of 12.14±5.26 years. Right ventricle dilatation and left ventricle dilatation were present in 61.5 and 42.9%, respectively. Left ventricle mass was abnormal in 21.9%; all patients had normal myocardial performance index, 31.4% had abnormal E/E', and left ventricle shortening fraction was low in 38.1%. Cardiac dilatation was best correlated with haemoglobin, aspartate aminotransferase, reticulocytosis and bilirubin. Best subset regression analysis yielded significant additional prediction for right ventricle or left ventricle dilatation with haemoglobin, bilirubin, and lactate dehydrogenase. Abnormal E/E' was solely predictable with haemoglobin level. Hydroxyurea-treated patients had improved diastolic function.
CONCLUSION: Right ventricle dilatation was more prevalent than left ventricle dilatation. The long-term consequences of right ventricular dilatation, clinical consequences, and association with pulmonary vasculopathy need to be further determined.

Entities:  

Keywords:  Sickle cell anaemia; child; drepanocytosis; right ventricle

Mesh:

Year:  2016        PMID: 27839523     DOI: 10.1017/S1047951116001633

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell disease.

Authors:  Vandana Sachdev; Matthew Hsieh; Neal Jeffries; Anna Noreuil; Wen Li; Stanislav Sidenko; Hwaida Hannoush; Emily Limerick; Delon Wilson; John Tisdale; Courtney Fitzhugh
Journal:  Blood Adv       Date:  2019-10-08

2.  Computer Algorithm-Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell Anemia.

Authors:  Mahogany Oldham; Anna Conrey; Corinne Pittman; Cameron Fisher; Simone Hargrett; Kamille West; Mary Jackson; Staci Martin; Matthew M Hsieh; Neal Jeffries; Mihailo Kaplarevic; Dachelle Johnson; Purevdorj Olkhanud; Courtney D Fitzhugh
Journal:  J Clin Pharmacol       Date:  2020-07-16       Impact factor: 2.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.